FreshSplash/Getty Images Researchers report that GLP-1 drugs prescribed for weight loss, like Ozempic and Mounjaro, may improve cognition and lower dementia and cardiovascular disease risk.

Semaglutide (known by its brandname Ozempic) has gained widespread attention ... The dose of semaglutide was gradually increased up to 1 mg or the maximum tolerated dose. During the last 4 ...

Accelerate your tech game Paid Content How the New Space Race Will Drive Innovation How the metaverse will change the future of work and society Managing the Multicloud The Future of the Internet ...

Experts have revealed the simple lifestyle change that can prevent dreaded side effects of weight loss jabs such as frailty and 'Ozempic face ... hormone GLP-1. But now, specialists have ...

Until you consider a Morgan Stanley projection that says by 2035, 24 million people will be taking Ozempic, Wegovy, or another GLP-1. Which makes sense. A study published in the Journal of the ...

A first randomized clinical trial shows that semaglutide use in type 1 diabetes is associated with improved glucose management, weight loss and lower insulin requirements. Semaglutide (known by its ...

To use Ozempic, you must consult an endocrinologist or a healthcare professional specialising in diabetes management. The medication is administered via a pre-filled injection pen, usually once a ...

"Ozempic Santa". His post read, "Nothing would do more to improve the health, lifespan and quality of life for Americans than making [GLP-1 drugs] super low cost to the public."<br>PC: @elonmusk ...

Even fewer opted for surgical interventions. Now GLP-1 drugs like Ozempic and Mounjaro have entered the chat. And they’ve changed the game entirely — how doctors talk to and think about patients.